Teriparatide-denosumab combo shows promise for osteoporosis

05/15/2013 | HealthDay News

Combining teriparatide and denosumab was more effective than using the drugs alone in increasing bone density in postmenopausal women with osteoporosis, a small study found. The combination also was more effective than any drugs on the market today, the study author said. The findings appeared online in The Lancet.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA